Portfolio

Company Announcements

Director/PDMR Shareholding

Related Companies

By LSE RNS

RNS Number : 3051A
Hikma Pharmaceuticals Plc
23 March 2017
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the Chief Strategy and Corporate Development Officer. This announcement is made in accordance with article 19.3 of MAR.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Bassam Kanaan

2

Reason for the notification

a)

Position/status

Chief Strategy and Corporate Development Officer / PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Disposal of 43,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.

c)

Price(s) and volume(s)

Price(s): £21.22

Volume(s): 43,000

d)

Aggregated information

Aggregated volume: 43,000

Price: £21.22

e)

Date of the transaction

20 to 22 March 2017

f)

Place of the transaction

London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

23 March 2017


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGCGDXCDDBGRX

Top of Page